GI OnDEMAND, a virtual integrated care platform, recently announced a partnership with Mindset Health, the creator of Nerva, a six-week gut-directed hypnotherapy program. The hypnotherapy program is delivered through a mobile app to help patients with irritable bowel syndrome (IBS) better manage their symptoms. GI OnDEMAND is a joint venture between the American College of Gastroenterology and Gastro Girl, Inc., ...

Scientists at McMaster University have identified new biomarkers for irritable bowel syndrome (IBS) in urine, which could lead to better treatments and reduce the need for costly and invasive colonoscopy procedures currently used for diagnosis. Little is known about the causes of IBS, a chronic and often debilitating gastrointestinal disorder which affects hundreds of thousands of Canadians in which diagnosis ...

Since most of the microbes in our gut are bacteria, they tend to hog much of the microbiome research limelight. But, lurking amongst the bacteria are other microbes such as single-cell eukaryotes (SCE) and viruses, which have been largely ignored until now. If doctors and scientists think of Blastocystis (one the most common gut SCEs) at all, they often regard it as ...

Cedars-Sinai has launched an initiative to accelerate the development of novel drugs, devices and therapies aimed at improving treatments for patients with gastrointestinal and metabolic diseases. Physician-scientists and others in the Medically Associated Science and Technology (MAST) Program are focusing their research expertise on disorders of the microbiome. This naturally occurring ecosystem of single-cell organisms — including bacteria, fungi, viruses ...